Funding and Investments

Jul 01, 2014
BioPharm International
Gene therapy, immune-oncology, and digital healthcare technologies offer investors promise for innovation investments.
Apr 22, 2014
By BioPharm International Editors
Lilly1s Cyramza is the first FDA-approved treatment for advanced gastric cancer after prior chemotherapy.
Apr 01, 2014
BioPharm International
Life-sciences companies continue upward momentum in 2014.
Jan 01, 2014
BioPharm International
Frenzy cools as investors seeking a quick return turn elsewhere.
Dec 16, 2013
BioPharm International
Caution should be taken when planning to crowdfund a biopharmaceutical startup.
Nov 01, 2013
BioPharm International
The JOBS Act and FDASIA show early signs of accelerating drug development.
Oct 01, 2013
BioPharm International
Early-stage companies are now embraced by buyers of new issues.
Aug 01, 2013
BioPharm International
By BioPharm International Editors
Pharmaceutical companies have stepped up gene therapy development in the wake of the approval of Glybera in 2012.
Jul 01, 2013
BioPharm International
Biotech companies raise most money in 13 years.
Apr 01, 2013
BioPharm International
Early-stage companies are finding alternatives to venture capital.
native1_300x100
lorem ipsum